{"title":"德国医疗保险体系中与肿瘤相关的治疗有所增加","authors":"Johanna Weber","doi":"10.19080/jtmp.2023.04.555631","DOIUrl":null,"url":null,"abstract":"In Germany, cancers are on the rise according to health insurance providers. To get an overview on the matter, data from the central agency of health insurance in Germany (Kassenärztliche Bundesvereinigung, KBV) have been analyzed regarding the frequency of cancer-related treatments between 2016 and 2022. Data hint to an increase in cancer-related treatments in German health insurants. Reasons for this could be missed check-up appointments due to lockdowns or other covid-related interventions.","PeriodicalId":287475,"journal":{"name":"Journal of Tumor Medicine & Prevention","volume":"2016 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Rise in Tumor-Related Treatments within the German Health-Insurance System\",\"authors\":\"Johanna Weber\",\"doi\":\"10.19080/jtmp.2023.04.555631\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"In Germany, cancers are on the rise according to health insurance providers. To get an overview on the matter, data from the central agency of health insurance in Germany (Kassenärztliche Bundesvereinigung, KBV) have been analyzed regarding the frequency of cancer-related treatments between 2016 and 2022. Data hint to an increase in cancer-related treatments in German health insurants. Reasons for this could be missed check-up appointments due to lockdowns or other covid-related interventions.\",\"PeriodicalId\":287475,\"journal\":{\"name\":\"Journal of Tumor Medicine & Prevention\",\"volume\":\"2016 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-08-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Tumor Medicine & Prevention\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.19080/jtmp.2023.04.555631\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Tumor Medicine & Prevention","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.19080/jtmp.2023.04.555631","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Rise in Tumor-Related Treatments within the German Health-Insurance System
In Germany, cancers are on the rise according to health insurance providers. To get an overview on the matter, data from the central agency of health insurance in Germany (Kassenärztliche Bundesvereinigung, KBV) have been analyzed regarding the frequency of cancer-related treatments between 2016 and 2022. Data hint to an increase in cancer-related treatments in German health insurants. Reasons for this could be missed check-up appointments due to lockdowns or other covid-related interventions.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
